INTRALIPID 10% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Intralipid 10%, and when can generic versions of Intralipid 10% launch?
Intralipid 10% is a drug marketed by Fresenius and is included in one NDA.
The generic ingredient in INTRALIPID 10% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INTRALIPID 10%?
- What are the global sales for INTRALIPID 10%?
- What is Average Wholesale Price for INTRALIPID 10%?
Summary for INTRALIPID 10%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 84 |
| DailyMed Link: | INTRALIPID 10% at DailyMed |
Recent Clinical Trials for INTRALIPID 10%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Rochester | Phase 2 |
| Yale University | Phase 1 |
| University of Kansas Medical Center | Early Phase 1 |
Pharmacology for INTRALIPID 10%
| Drug Class | Lipid Emulsion |
US Patents and Regulatory Information for INTRALIPID 10%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius | INTRALIPID 10% | soybean oil | INJECTABLE;INJECTION | 017643-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
